CZMSX
Price
$17.98
Change
-$0.03 (-0.17%)
Updated
Jul 31 closing price
Net Assets
1.3B
VSMAX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

CZMSX vs VSMAX

CZMSX vs VSMAX Comparison Chart in %
View a ticker or compare two or three
VS
CZMSX vs. VSMAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CZMSX is a Hold and VSMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMAX has more cash in the bank: 189B vs. CZMSX (1.3B). VSMAX pays higher dividends than CZMSX: VSMAX (1.21) vs CZMSX (0.57). CZMSX was incepted earlier than VSMAX: CZMSX (10 years) vs VSMAX (26 years). CZMSX (1.05) is less costly to investors than VSMAX (0.05). CZMSX is a more actively managed with annual turnover of: 109.00 vs. VSMAX (17.00). CZMSX has a lower initial minimum investment than VSMAX: CZMSX (100) vs VSMAX (3000). VSMAX annual gain was more profitable for investors over the last year : 22.58 vs. CZMSX (15.34). VSMAX return over 5 years is better than : 35.11 vs. CZMSX (-13.40).
CZMSXVSMAXCZMSX / VSMAX
Total Expense Ratio0.960.051,920%
Annual Report Gross Expense Ratio1.050.052,100%
Fund Existence10 years26 years-
Gain YTD17.36314.588119%
Front LoadN/AN/A-
Min. Initial Investment10030003%
Min. Initial Investment IRAN/AN/A-
Net Assets1.3B189B1%
Annual Yield % from dividends0.571.2147%
Returns for 1 year15.3422.5868%
Returns for 3 years17.6343.4241%
Returns for 5 years-13.4035.11-38%
Returns for 10 yearsN/A155.96-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BQLCX23.420.17
+0.73%
Bright Rock Quality Large Cap Instl
GSPQX20.020.12
+0.60%
Goldman Sachs US Eq Div and Premium C
GSIYX24.29N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R6
CCWIX21.73-0.15
-0.69%
Baird Chautauqua International Gr Instl
RYOAX66.89-1.55
-2.26%
Rydex Biotechnology H